This transcriptional finding combined with our genetic main result, that the homozygous GG subjects have about a twofold higher risk of developing MDD treatment resistance, might suggest that this SNP may represent a risk factor for TRD due to alteration of PSMD13 transcription. This evidence concerns the gene PSMD13 and major depressive disorder.